Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-01

Clinical Trial Update: Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing reactogenicity of Cervarix and Gardasil in UK adolescent girls.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cervarix (human papillomavirus vaccine, bivalent)
  • Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Public Health England | Conditions: HPV Infections | Phase 4 | Status: COMPLETED